Details

DSEN Abstract: No evidence identified interventions that decrease the risk of adverse cardiac events for patients receiving chemotherapy and serotonin 5-hydroxytryptamine 3 receptor (5-HT3) antagonists - CIHR

Metadata and links for an archived snapshot.

Source: Canadian Institutes of Health Research
Date: Apr 10, 2025 · edition #2
Timestamp: 2025-04-10T10:51:00.190Z
Language: en
Original URL: https://cihr-irsc.gc.ca/e/52121.html
Replay URL: https://replay.healtharchive.ca/job-2/20250410105100/https://cihr-irsc.gc.ca/e/52121.html#ha_snapshot=125750
ID: 125750
Status: 200
Type: text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots